L.p. 14159, - Net Worth and Insider Trading
L.p. 14159, Net Worth
The estimated net worth of L.p. 14159, is at least $379 Million dollars as of 2024-09-20. L.p. 14159, is the Director, 10% Owner of ACADIA Pharmaceuticals Inc and owns about 23,067,648 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $379 Million. Details can be seen in L.p. 14159,'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that L.p. 14159, has not made any transactions after 2016-01-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of L.p. 14159,
L.p. 14159, Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, L.p. 14159, owns 8 companies in total, including Incyte Corp (INCY) , Aceragen Inc (ACGN) , and ACADIA Pharmaceuticals Inc (ACAD) among others .
Click here to see the complete history of L.p. 14159,’s form 4 insider trades.
Insider Ownership Summary of L.p. 14159,
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INCY | Incyte Corp | 2013-06-11 | director |
| ACGN | Aceragen Inc | 2014-03-10 | director |
| ACAD | ACADIA Pharmaceuticals Inc | 2016-01-07 | director |
 | | 2016-02-02 | director & 10 percent owner |
| | 2012-07-19 | director |
| | 2013-05-17 | director |
| | 2013-08-01 | 10 percent owner |
| | 2012-07-19 | director |
L.p. 14159, Latest Holdings Summary
L.p. 14159, currently owns a total of 1 stock. L.p. 14159, owns 23,067,648 shares of ACADIA Pharmaceuticals Inc (ACAD) as of January 7, 2016, with a value of $379 Million.
Latest Holdings of L.p. 14159,
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2016-01-07 | 23,067,648 | 16.42 | 378,770,780 |
Holding Weightings of L.p. 14159,
L.p. 14159, Form 4 Trading Tracker
According to the SEC Form 4 filings, L.p. 14159, has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the acquisition of 2,586,206 shares on January 7, 2016, which cost L.p. 14159, around $75 Million.
Insider Trading History of L.p. 14159,
- 1
L.p. 14159, Trading Performance
GuruFocus tracks the stock performance after each of L.p. 14159,'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by L.p. 14159, is 12.29%. GuruFocus also compares L.p. 14159,'s trading performance to market benchmark return within the same time period. The performance of stocks bought by L.p. 14159, within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how L.p. 14159,'s insider trading performs compared to the benchmark.
Performance of L.p. 14159,
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -32.61 | | | | | |
| Relative Return to S&P 500(%) | -29.37 | | | | | |
L.p. 14159, Ownership Network
L.p. 14159, Owned Company Details
What does Incyte Corp do?
Who are the key executives at Incyte Corp?
L.p. 14159, is the director of Incyte Corp. Other key executives at Incyte Corp include Principal Accounting Officer Thomas Tray , EVP & General Manager & Europe Jonathan Elliott Dickinson , and EVP & Chief Medical Officer Steven H Stein .
Incyte Corp (INCY) Insider Trades Summary
Over the past 18 months, L.p. 14159, made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 40,484 shares made by Steven H Stein , a net sale of 28,618 shares made by Barry P Flannelly , and a net sale of 3,324 shares made by Thomas Tray .
In summary, during the past 3 months, insiders sold 46,037 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 46,037 shares. During the past 18 months, 105,553 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 105,553 shares.
Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Incyte Corp Insider Transactions
L.p. 14159, Mailing Address
Above is the net worth, insider trading, and ownership report for L.p. 14159,. You might contact L.p. 14159, via mailing address: 860 Washington Street, 3rd Floor, New York Ny 10014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
